Bradsher Neal C 4

What Happened
Neal C. Bradsher, a director and 10% owner of STAAR Surgical Company (STAA), received an award of 7,524 derivative securities on March 6, 2026. The Form 4 reports the grant as an acquisition (code A) at $0.00 — i.e., a grant of stock options/awards as compensation rather than a cash purchase or sale. No exercise or sale occurred in this filing.

Key Details

• Transaction date: March 6, 2026; Form 4 filed March 10, 2026. (No late-filing flag provided in the excerpt.)
• Transaction type: Grant/Award of derivative securities (options); reported price $0.00 (grant, not purchase).
• Number of options granted: 7,524.
• Shares/options owned after the transaction: Not specified in the provided filing excerpt.
• Footnotes:
  • F1: Options vest and become exercisable on the earlier of (a) June 18, 2026 or (b) the Issuer’s 2026 annual meeting, subject to continuous service.
  • F2: Options were granted as director compensation under the Issuer’s Amended and Restated Omnibus Equity Incentive Plan.

Context
This is a compensation grant to a director (and 10% owner), a routine corporate practice to compensate board members. It is an award of options (a derivative); there was no immediate exercise or sale reported. Such grants reflect compensation policy more than an insider trading signal — purchases or sales by insiders typically convey stronger trading intent.